Peterson's petition highlights that Minerva's patent application disclosed significant safety issues with its original endometrial ablation device, contradicting later testimony during whistleblower arbitration.
The patent application emphasizes that the original design's defect could 'plug' uterine perforations, leading to dangerous misdiagnoses, suggesting prior knowledge of risks associated with the device.
Collection
[
|
...
]